On January 16, 2016, the 11th and final subject received their first treatment in our ongoing study of MDMA-assisted therapy for social anxiety in adults on the autism spectrum. “We wish to express our gratitude for the feedback and guidance that the participants have offered generously at every step in the research process,” write researchers Charles Grob, M.D., and Alicia Danforth, Ph.D., in the Winter 2015 MAPS Bulletin article. “Their insights have helped the team learn how to work with autistic co-collaborators to explore ways in which MDMA-assisted therapy might bring relief for moderate to severe social anxiety.” Sponsored by MAPS, this is a collaborative study between MAPS and the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, with blood plasma biomarker analysis being conducted by researchers at Stanford University.